Stay updated on Safety of DCR HBVS in Hepatitis B - Clinical Trial
Sign up to get notified when there's something new on the Safety of DCR HBVS in Hepatitis B - Clinical Trial page.

Latest updates to the Safety of DCR HBVS in Hepatitis B - Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the DCR-HBVS chronic hepatitis B study is displayed, including its study details, participant criteria, treatment arms, and measured outcomes.SummaryDifference84%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are adopting “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms appearing during the transition.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. This prevents users from viewing the study details, locations, and related information.SummaryDifference22%

Stay in the know with updates to Safety of DCR HBVS in Hepatitis B - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of DCR HBVS in Hepatitis B - Clinical Trial page.